Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status

Abstract Introduction Routine care studies of psoriatic arthritis (PsA) and ankylosing spondylitis (AS) demonstrated attenuated responses to tumor necrosis factor inhibitors in current/past versus never smokers. This post hoc analysis assessed tofacitinib efficacy and safety in patients with PsA or...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alexis Ogdie, Lars E. Kristensen, Enrique R. Soriano, Servet Akar, Yanhui Sun, David Gruben, Lara Fallon, Cassandra D. Kinch, Dafna D. Gladman
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2024-09-01
coleção:	Rheumatology and Therapy
Assuntos:	Ankylosing spondylitis Inflammation Interventional studies JAK inhibitors Psoriatic arthritis Smoking
Acesso em linha:	https://doi.org/10.1007/s40744-024-00711-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!